Hypokinetic dysarthria in Parkinson's disease (PD) can be characterized by monotony of pitch and loudness, reduced stress, variable rate, imprecise consonants, and a breathy and harsh voice. Using acoustic analysis, we studied the effects of high-frequency repetitive transcranial magnetic stimulation (rTMS) applied over the primary orofacial sensorimotor area (SM1) and the left dorsolateral prefrontal cortex (DLPFC) on motor aspects of voiced speech in PD. Twelve non-depressed and non-demented men with PD (mean age 64.58 ± 8.04 years, mean PD duration 10.75 ± 7.48 years) and 21 healthy age-matched men (a control group, mean age 64 ± 8.55 years) participated in the speech study. The PD patients underwent two sessions of 10 Hz rTMS over the dominant hemisphere with 2,250 stimuli/day in a random order: (1) over the SM1; (2) over the left DLPFC in the "on" motor state. Speech examination comprised the perceptual rating of global speech performance and an acoustic analysis based upon a standardized speech task. The Mann-Whitney U test was used to compare acoustic speech variables between controls and PD patients. The Wilcoxon test was used to compare data prior to and after each stimulation in the PD group. rTMS applied over the left SM1 was associated with a significant increase in harmonic-to-noise ratio and net speech rate in the sentence tasks. With respect to the vowel task results, increased median values and range of Teager-Kaiser energy operator, increased vowel space area, and significant jitter decrease were observed after the left SM1 stimulation. rTMS over the left DLPFC did not induce any significant effects. The positive results of acoustic analysis were not reflected in a subjective rating of speech performance quality as assessed by a speech therapist. Our pilot results indicate that one session of rTMS applied over the SM1 may lead to measurable improvement in voice quality and intensity and an increase in speech rate and tongue movements. Nevertheless, these changes were not accompanied by changes in a perceptual evaluation of speech performance by a speech therapist. Future placebo-controlled studies in larger patient cohorts should verify if rTMS would be clinically useful for treating hypokinetic dysarthria in PD.

1st Department of Neurology Faculty of Medicine St Anne's University Hospital and CEITEC MU Pekarska 53 656 91 Brno Czech Republic

Zobrazit více v PubMed

Proc Natl Acad Sci U S A. 1993 Feb 1;90(3):878-82 PubMed

Exp Brain Res. 2003 Jan;148(1):1-16 PubMed

Mov Disord. 2010 Oct 30;25(14):2311-7 PubMed

J Neural Transm (Vienna). 2009 Sep;116(9):1093-101 PubMed

Mov Disord. 2007 Dec;22(16):2386-93 PubMed

Trends Neurosci. 1990 Jul;13(7):254-8 PubMed

Acta Psychol (Amst). 1998 Nov;100(1-2):71-84 PubMed

Arch Gen Psychiatry. 1961 Jun;4:561-71 PubMed

PLoS One. 2009 Aug 21;4(8):e6725 PubMed

J Psychiatr Res. 1975 Nov;12(3):189-98 PubMed

J Speech Lang Hear Res. 2010 Feb;53(1):114-25 PubMed

Mov Disord. 2005 Sep;20(9):1178-84 PubMed

Neuropsychopharmacology. 2010 Jan;35(1):70-85 PubMed

J Commun Disord. 2005 May-Jun;38(3):187-96 PubMed

Folia Phoniatr Logop. 2010;62(3):104-9 PubMed

J Neurol. 2004 Mar;251(3):327-34 PubMed

Mov Disord. 2007 Jul 30;22(10):1518-1519 PubMed

Lancet Neurol. 2004 Sep;3(9):547-56 PubMed

Clin Pract Epidemiol Ment Health. 2011;7:167-77 PubMed

Hum Brain Mapp. 2010 Feb;31(2):222-36 PubMed

J Neural Transm (Vienna). 2010 Jan;117(1):105-22 PubMed

Neurology. 1990 Oct;40(10):1529-34 PubMed

Parkinsonism Relat Disord. 2000 Jul 1;6(3):165-170 PubMed

Neuropsychopharmacology. 2004 Jun;29(6):1172-89 PubMed

J Commun Disord. 2005 May-Jun;38(3):215-30 PubMed

Mov Disord. 2009 Feb 15;24(3):357-63 PubMed

J Speech Hear Res. 1993 Apr;36(2):294-310 PubMed

J Neural Transm (Vienna). 2013 Feb;120(2):319-29 PubMed

J Neurosci. 2001 Aug 1;21(15):RC157 PubMed

Brain Res Brain Res Rev. 1995 Jan;20(1):91-127 PubMed

N Engl J Med. 1998 Oct 15;339(16):1105-11 PubMed

Eur J Neurosci. 2007 Oct;26(7):2005-24 PubMed

Adv Neurol. 1990;53:245-9 PubMed

Expert Rev Neurother. 2008 Feb;8(2):297-309 PubMed

Mov Disord. 2007 Oct 31;22(14):2043-51 PubMed

J Neurol Neurosurg Psychiatry. 2001 Oct;71(4):493-8 PubMed

J Neural Transm (Vienna). 2010 Feb;117(2):197-205 PubMed

Eur J Neurosci. 1999 Mar;11(3):1011-36 PubMed

Acta Neurol Scand. 2006 Feb;113(2):92-9 PubMed

Mov Disord. 2007 Oct 15;22(13):1901-11 PubMed

J Voice. 2008 May;22(3):365-72 PubMed

J Neurol Sci. 2005 Mar 15;229-230:157-61 PubMed

Eur J Neurol. 2012 Feb;19(2):340-7 PubMed

Speech disorders in Parkinson's disease: early diagnostics and effects of medication and brain stimulation